SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005360
Filing Date
2016-05-05
Accepted
2016-05-05 09:20:43
Documents
87
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amag-20160331x10q.htm 10-Q 1842502
2 EX-31.1 amag-20160331ex311d6775a.htm EX-31.1 18873
3 EX-31.2 amag-20160331ex312913787.htm EX-31.2 18977
4 EX-32.1 amag-20160331ex321ab8181.htm EX-32.1 9295
5 EX-32.2 amag-20160331ex322dbd0c1.htm EX-32.2 9598
  Complete submission text file 0001558370-16-005360.txt   9817787

Data Files

Seq Description Document Type Size
6 EX-101.INS amag-20160331.xml EX-101.INS 2399677
7 EX-101.SCH amag-20160331.xsd EX-101.SCH 67646
8 EX-101.CAL amag-20160331_cal.xml EX-101.CAL 111902
9 EX-101.DEF amag-20160331_def.xml EX-101.DEF 330950
10 EX-101.LAB amag-20160331_lab.xml EX-101.LAB 651063
11 EX-101.PRE amag-20160331_pre.xml EX-101.PRE 514649
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 161621870
SIC: 2834 Pharmaceutical Preparations